BioNTech SE (ETR:22UA)
89.00
-2.85 (-3.10%)
At close: Aug 26, 2025, 5:30 PM CET
BioNTech SE Revenue
BioNTech SE had revenue of 260.80M EUR in the quarter ending June 30, 2025, with 102.64% growth. This brings the company's revenue in the last twelve months to 2.88B, up 6.98% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.
Revenue (ttm)
2.88B
Revenue Growth
+6.98%
P/S Ratio
7.51
Revenue / Employee
425.04K
Employees
6,772
Market Cap
21.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.75B | -1.07B | -27.96% |
Dec 31, 2023 | 3.82B | -13.49B | -77.94% |
Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
BioNTech SE News
- 1 day ago - Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' - Benzinga
- 8 days ago - Pfizer/BioNTech updated COVID vaccine authorized in Canada - Seeking Alpha
- 12 days ago - CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Wallstreet:Online
- 12 days ago - CureVac's 2025 Mid-Year Financial Surge & Key Business Insights - Wallstreet:Online
- 15 days ago - Pfizer/BioNTech may not win FDA renewal for pediatric COVID shot: report - Seeking Alpha
- 19 days ago - GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled - Seeking Alpha
- 19 days ago - GSK to be paid up to £370 million after patent row settles in US - Evening Standard
- 19 days ago - CureVac settles patent dispute litigation with Pfizer and BioNTech - Reuters